FDA removes black box warning on testosterone: what it means
The United States Food and Drug Administration has announced a landmark decision to remove the black box warning regarding cardiovascular risks from all testosterone replacement therapy products. This significant regulatory change, based on comprehensive scientific evidence from the TRAVERSE trial…
Read more






